adolescents: results from the National Comorbidity Survey Replication-Adolescent Supplement (NCS-A). Lifetime prevalence of mental disorders in U.S. Merikangas KR, He JP, Burstein M, Swanson SA, Avenevoli S, Cui L, Benjet C, Georgiades K, Swendsen J.Mortality, ADHD, and psychosocial adversity in adults with childhood ADHD: a prospective study. Barbaresi WJ, Colligan RC, Weaver AL, Voigt RG, Killian JM, Katusic SK.Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011. Visser SN, Danielson ML, Bitsko RH, Holbrook JR, Kogan MD, Ghandour RM, Perou R, Blumberg SJ.Medication use increased 4% overall from 2007 to 2011, particularly among male teens.An estimated 69.3% of children with a current diagnosis of ADHD received medication for ADHD. Figure 2 is based on data from the NSCH and shows medication use among children with ADHD in 2011.Medication can be used to effectively treat ADHD symptoms of impulsivity, inattention, and hyperactivity, and is the single most effective treatment for reducing ADHD symptoms.Approximately one-third of children diagnosed with ADHD retain the diagnosis into adulthood.The median age of diagnosis for mild ADHD was 7 years.The median age of diagnosis for moderate ADHD was 6 years.The median age of diagnosis for severe ADHD was 4 years.More severe cases of ADHD in children, as described by parents, were diagnosed earlier.Based on data from the NSCH, the median age of onset for children with current ADHD was 6 years.Trends in Prevalence of Children Ever Diagnosed with ADHD (2003,2007,2011) Year Research Training and Career Development Opportunities.Research Conducted at NIMH (Intramural Research Program).Upcoming Observances and Related Events.Contribute to Mental Health Research Mobile navigation
0 kommentar(er)
